149 related articles for article (PubMed ID: 2444539)
1. Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.
Lise LD; Mazier D; Jolivet M; Audibert F; Chedid L; Schlesinger D
Infect Immun; 1987 Nov; 55(11):2658-61. PubMed ID: 2444539
[TBL] [Abstract][Full Text] [Related]
2. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
[TBL] [Abstract][Full Text] [Related]
3. Effect of priming with carrier on response to conjugate vaccine.
Di John D; Wasserman SS; Torres JR; Cortesia MJ; Murillo J; Losonsky GA; Herrington DA; Stürcher D; Levine MM
Lancet; 1989 Dec; 2(8677):1415-8. PubMed ID: 2480499
[TBL] [Abstract][Full Text] [Related]
4. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.
Etlinger HM; Felix AM; Gillessen D; Heimer EP; Just M; Pink JR; Sinigaglia F; Stürchler D; Takacs B; Trzeciak A
J Immunol; 1988 Jan; 140(2):626-33. PubMed ID: 3275719
[TBL] [Abstract][Full Text] [Related]
5. Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.
Etlinger HM; Heimer EP; Trzeciak A; Felix AM; Gillessen D
Immunology; 1988 Jul; 64(3):551-8. PubMed ID: 3044983
[TBL] [Abstract][Full Text] [Related]
6. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.
Kumar A; Arora R; Kaur P; Chauhan VS; Sharma P
J Immunol; 1992 Mar; 148(5):1499-505. PubMed ID: 1371529
[TBL] [Abstract][Full Text] [Related]
7. Production of anti-sporozoite antibodies in absence of response to carrier by coupling an MDP derivative to a malaria peptide-tetanus toxoid conjugate.
Clough ER; Jolivet M; Audibert F; Barnwell JW; Schlesinger DH; Chedid L
Biochem Biophys Res Commun; 1985 Aug; 131(1):70-6. PubMed ID: 4038309
[TBL] [Abstract][Full Text] [Related]
8. Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.
Chabalgoity JA; Villareal-Ramos B; Khan CM; Chatfield SN; de Hormaeche RD; Hormaeche CE
Infect Immun; 1995 Jul; 63(7):2564-9. PubMed ID: 7790070
[TBL] [Abstract][Full Text] [Related]
9. Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components.
Barington T; Skettrup M; Juul L; Heilmann C
Infect Immun; 1993 Feb; 61(2):432-8. PubMed ID: 7678586
[TBL] [Abstract][Full Text] [Related]
10. Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.
Herrington DA; Clyde DF; Davis JR; Baqar S; Murphy JR; Cortese JF; Bank RS; Nardin E; DiJohn D; Nussenzweig RS
Bull World Health Organ; 1990; 68 Suppl(Suppl):33-7. PubMed ID: 2094588
[TBL] [Abstract][Full Text] [Related]
11. Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate.
Kaliyaperumal A; Chauhan VS; Talwar GP; Raghupathy R
Eur J Immunol; 1995 Dec; 25(12):3375-80. PubMed ID: 8566026
[TBL] [Abstract][Full Text] [Related]
12. Effects of interferons on immune response to a synthetic peptide malaria sporozoite vaccine in non-immune adults.
Stürchler D; Berger R; Etlinger H; Fernex M; Matile H; Pink R; Schlumbom V; Just M
Vaccine; 1989 Oct; 7(5):457-61. PubMed ID: 2479187
[TBL] [Abstract][Full Text] [Related]
13. Antibody responses to a synthetic peptide-based malaria vaccine candidate: influence of sequence variants of the peptide.
Etlinger HM; Renia L; Matile H; Manneberg M; Mazier D; Trzeciak A; Gillessen D
Eur J Immunol; 1991 Jun; 21(6):1505-11. PubMed ID: 2044658
[TBL] [Abstract][Full Text] [Related]
14. Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis.
Jarząb A; Witkowska D; Ziomek E; Setner B; Czajkowska A; Dorot M; Szewczuk Z; Gamian A
Vaccine; 2018 Jul; 36(31):4641-4649. PubMed ID: 29960802
[TBL] [Abstract][Full Text] [Related]
15. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines.
Schutze MP; Leclerc C; Jolivet M; Audibert F; Chedid L
J Immunol; 1985 Oct; 135(4):2319-22. PubMed ID: 2411793
[TBL] [Abstract][Full Text] [Related]
16. Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivative.
Clough ER; Audibert FM; Barnwell JW; Schlesinger DH; Arnon R; Chedid LA
Infect Immun; 1985 Jun; 48(3):839-42. PubMed ID: 3997250
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.
Herrington DA; Clyde DF; Losonsky G; Cortesia M; Murphy JR; Davis J; Baqar S; Felix AM; Heimer EP; Gillessen D
Nature; 1987 Jul 16-22; 328(6127):257-9. PubMed ID: 2439920
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin A supplementation on immunoglobulin G subclass responses to tetanus toxoid in children.
Semba RD; Muhilal ; Scott AL; Natadisastra G; West KP; Sommer A
Clin Diagn Lab Immunol; 1994 Mar; 1(2):172-5. PubMed ID: 7496940
[TBL] [Abstract][Full Text] [Related]
19. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax.
Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT
Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha and synthetic peptide malaria sporozoite vaccine in non-immune adults: antibody response after 40 weeks.
Stürchler D; Zimmer G; Berger R; Etlinger H; Fernex M; Matile H; Just M
Bull World Health Organ; 1990; 68 Suppl(Suppl):38-41. PubMed ID: 2094589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
